Scientists Confirm That 14 Drugs Cannot Beat The Power Of Turmeric

Over 5600 peer-reviewed and published biomedical studies have turmeric as their subject, due to its medicinal properties and components, primarily curcumin. scientists-confirm-that-14-drugs-cannot-beat-the-power-of-turmeric

Nowadays, turmeric is one of the most thoroughly researched plants in existence. The truth is that researches reveal over 600 potential preventive and therapeutic applications of this sacred plant, as well as 175 distinct beneficial physiological effects.

Consequently, it is no wonder that a growing number of studies have concluded that this magical spice compares favorably to a variety of conventional medications, such as:

  • Corticosteroids (steroid medications):The journal Phytotherapy Research published a study 1999 which discovered that the primary polyphenol in turmeric, the saffron colored pigment known as curcumin, compared favorably to steroids in the management of chronic anterior uveitis, an inflammatory eye disease.  A 2003 study published in Cancer Letters found it advantageous when compared favorably to dexamethasone in a lung ischaemia-repurfusion injury model. Curcumin was also found as an alternative therapy by a 2008 study published in Critical Care Medicine, where it compared favorably to the corticosteroid drug dexamethasone in the animal model for protecting lung transplantation-associated injury by down-regulating inflammatory genes.
  • Aspirin (blood thinner):Curcumin has anti-platelet and prostacyclin modulating effects compared to aspirin, which was shown in a 1986 in vitro and ex vivo study published in the journal Arzneimittelforschung. This means that it may have value in patients prone to vascular thrombosis and requiring anti-arthritis therapy.
  • Lipitor/Atorvastatin(cholesterol medication): Drugs in R & D published a study in 2008 which revealed that a standardized preparation of curcuminoids from Turmeric compared favorably to the drug atorvastatin (its trade name is Lipitor) on endothelial dysfunction, the underlying pathology of the blood vessels that drives atherosclerosis, in association with reductions in inflammation and oxidative stress in type 2 diabetic patients.
  • Prozac/Fluoxetine & Imipramine  (antidepressants):That curcumin compared favorably to both drugs in reducing depressive behavior was found in a 2011 study conducted on an animal model, published in the journal Acta Poloniae Pharmaceutica.
  • Metformin (diabetes drug): Another study in 2009, published in the journal Biochemitry and Biophysical Research Community, explored how curcumin might be valuable in treating diabetes. It results proved it activates AMPK (which increases glucose uptake) and suppresses gluconeogenic gene expression  (which suppresses glucose production in the liver) in hepatoma cells. What is even more interesting, the study discovered curcumin, in the form of THC(tetrahydrocurcuminoids) to have 500 times to 100,000 times more potential than metformin in activating AMPK and its downstream target acetyl-CoA carboxylase (ACC).
  • Oxaliplatin (chemotherapy drug): The International Journal of Cancer in 2007 published a study which discovered that curcumin compares favorably with oxaliplatin as an antiproliferative agenet in colorectal cell lines.
  • Anti-inflammatory Drugs: The journal Oncogene published a study in 2004 whose results proved that curcumin ,as well as resveratrol, were effective alternatives to numerous drugs, including aspirin, dexamethasone, celecoxib, ibuprofen, naproxen, indomethacin, sulindac, phenylbutazone, diclofenac, and tamoxifen in exerting anti-inflammatory and anti-proliferative activity against tumor cells.

Studies For Its Application in Cancer Treatment

The remarkable therapeutic features of turmeric and its components are also revealed in research on drug resistant- and multi-drug resistant cancers.  There are numerous substances with demonstrable efficacy against these chemotherapy- and radiation-resistant cancers, but curcumin tops both, drug resistant and multi- drag resistant cancers.

There is a large number of studies which indicate that curcumin can induce cell death or sensitize drug-resistant cancer cell lines to conventional treatment. Numerous studies also prove its ability to either induce cell death or sensitize multi-drug resistant cancer cell lines to conventional treatment.

As we mentioned above, turmeric (curcumin) is one of the most studied and praised plants worldwide. Considering its strong track record, its use as both, food and medicine in a wide range of cultures, for thousands of years, a strong argument can be made for using curcumin as a drug alternative or adjuvant in cancer treatment.

However, the best variant is to use it on a daily basis, in a certified organic form(non-irradiated) in lower culinary doses, so you won’t need large doses later in life after a serious disease sets in.  Do not self-medicate with ‘nutraceuticals’, but nourish yourself to feel all the benefits of running a healthy lifestyle.

Source: Eat Local Grown


Leave a Reply